The Vitamin D/Vitamin D receptor (VDR) axis in muscle atrophy and sarcopenia
The Vitamin D/Vitamin D receptor (VDR) axis in muscle atrophy and sarcopenia
复制标题
肌肉萎缩和肌肉减少症中的维生素 D/维生素 D 受体 (VDR) 轴
DOI:
10.1016/j.cellsig.2022.110355
复制
发表时间:
2022-06-06
影响因子:
4.8
通讯作者:
Atherton, Philip J.
中科院分区:
文献类型:
--
作者:
Bollen, Shelby E.;Bass, Joseph J.;Atherton, Philip J.
Muscle atrophy and sarcopenia (the term given to the age-related decline in muscle mass and function), influence an individuals risk of falls, frailty, functional decline, and, ultimately, impaired quality of life. Vitamin D deficiency (low serum levels of 25-hydroxyvitamin D (25(OH)D-3)) has been reported to impair muscle strength and increase risk of sarcopenia. The mechanisms that underpin the link between low 25(OH)D-3 and sarcopenia are yet to be fully understood but several lines of evidence have highlighted the importance of both genomic and non-genomic effects of active vitamin D (1,25-dihydroxyvitamin D (1,25(OH)(2)D-3)) and its nuclear vitamin D receptor (VDR), in skeletal muscle functioning. Studies in vitro have demonstrated a key role for the vitamin D/ VDR axis in regulating biological processes central to sarcopenic muscle atrophy, such as proteolysis, mitochondrial function, cellular senescence, and adiposity. The aim of this review is to provide a mechanistic overview of the proposed mechanisms for the vitamin D/VDR axis in sarcopenic muscle atrophy.